Back to the complete issue
Wednesday, 27 November 2019

Boehringer Ingelheim debuts poultry virus vaccine in Egypt

German pharma company Boehringer Ingelheim’s animal health unit has launched a new vaccine in Egypt to guard against Marek’s disease (MD), a contagious virus that affects poultry, according to an emailed statement (pdf). Egypt is the first country in which the company is debuting the vaccine, where poultry flocks have seen “recurrent outbreaks of MD with increases in virus virulence.”

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2018 Enterprise Ventures LLC.